Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Informatics

Date Submitted: Jan 20, 2019
Open Peer Review Period: Jan 23, 2019 - Mar 3, 2019
Date Accepted: Mar 27, 2019
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

The Use of Artificially Intelligent Self-Diagnosing Digital Platforms by the General Public: Scoping Review

Aboueid S, Liu R, Desta BN, Chaurasia A, Ebrahim S

The Use of Artificially Intelligent Self-Diagnosing Digital Platforms by the General Public: Scoping Review

JMIR Med Inform 2019;7(2):e13445

DOI: 10.2196/13445

PMID: 31042151

PMCID: 6658267

The use of artificially-intelligent self-diagnosing digital platforms by the general public: A scoping review

  • Stephanie Aboueid; 
  • Rebecca Liu; 
  • Binyam Negussie Desta; 
  • Ashok Chaurasia; 
  • Shanil Ebrahim

ABSTRACT

Background:

Artificially-intelligent self-diagnosing digital platforms are becoming widely available and used by the general population. Little is known about the body of knowledge surrounding this technology.

Objective:

The objectives of this scoping review are: 1) to systematically map the extent and nature of the literature and topic areas pertaining to digital platforms that use computerized algorithms to provide a list of potential diagnoses and 2) to identify key knowledge gaps.

Methods:

The following databases were searched: ACM, IEEE, Google Scholar, Open Grey, ProQuest Dissertations and Theses. The search strategy was developed and refined with the assistance of a librarian and consisted of three main concepts: 1) self-diagnosis; 2) digital platforms; 3) public or patients. The search generated 2,536 articles from which 217 were duplicates. Following the Tricco et al. 2018 checklist, two researchers screened the titles and abstracts (n=2,316) and full-texts (n=104), independently. A total of 19 articles were included for review and data were retrieved following a data-charting form that was pre-tested by the research team.

Results:

Included articles were mainly conducted in the US (n=10) or the UK (n=4). Among the articles, topic areas included: accuracy or correspondence with a doctor’s diagnosis (n=6), commentaries (n=2), regulation (n=3), sociological (n=2), user experience (n=2), theoretical (n=1), privacy and security (n=1), ethical (n=1), design (n=1). Individuals who do not have access to health care and perceive to have a stigmatizing condition are more likely to use this technology. The accuracy of this technology to provide a correct first diagnosis varied substantially based on the disease examined and platform used. Factors influencing accuracy include the design of the online platform and sociodemographic profile of the user. Regulation of this technology is lacking in most parts of the world; however, they are currently under development.

Conclusions:

There are prominent research gaps in the literature surrounding the use of self-diagnosing AI digital platforms. Given the variety of digital platforms and the types of diseases they cover, measuring accuracy is cumbersome. More research is needed to inform regulations and to consider user experience.


 Citation

Please cite as:

Aboueid S, Liu R, Desta BN, Chaurasia A, Ebrahim S

The Use of Artificially Intelligent Self-Diagnosing Digital Platforms by the General Public: Scoping Review

JMIR Med Inform 2019;7(2):e13445

DOI: 10.2196/13445

PMID: 31042151

PMCID: 6658267

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.